Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Tunica Albuginea who wrote (2202)	11/7/1997 12:11:00 PM
From: MIKE DUBIS	Read Replies (1) \| Respond to of 23519

TA. I would like, if you would, to give me your opinion as to whether or not you feel the next support level for VVUS is the mid to high teens Thanks in advance for your input

To: Tunica Albuginea who wrote (2202)	11/7/1997 3:16:00 PM
From: BigKNY3	Read Replies (2) \| Respond to of 23519

TA: Under FDA regulations, it is permissable for pharmaceutical company executives to discuss products currently under development by their companies including the recent Pfizer R&D analysts' meeting. I note your obsession with attempting to find negative things to write about Viagra (even imaginary events!). To me, it indicates your real concern over the possible impact an effective, safe, less expensive oral agent will have on the sales of MUSE. This is the very same concern that many investors and Wall Street brokers are having! BigKNY3